Ralliant Corporation $RAL Shares Sold by TD Asset Management Inc

TD Asset Management Inc lowered its position in shares of Ralliant Corporation (NYSE:RAL) by 21.6% during the third quarter, Holdings Channel reports. The firm owned 213,180 shares of the company’s stock after selling 58,832 shares during the quarter. TD Asset Management Inc’s holdings in Ralliant were worth $9,322,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares in the last quarter. Dodge & Cox purchased a new position in shares of Ralliant in the second quarter valued at $523,571,000. Viking Global Investors LP acquired a new position in Ralliant during the second quarter worth about $257,200,000. State Street Corp acquired a new stake in shares of Ralliant in the second quarter valued at approximately $213,096,000. Finally, Flossbach Von Storch SE lifted its stake in Ralliant by 1.7% in the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after buying an additional 67,963 shares in the last quarter.

Insider Buying and Selling at Ralliant

In other Ralliant news, Director Kate Mitchell bought 2,350 shares of the stock in a transaction on Tuesday, February 10th. The stock was purchased at an average price of $42.48 per share, with a total value of $99,828.00. Following the acquisition, the director owned 8,411 shares of the company’s stock, valued at approximately $357,299.28. The trade was a 38.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Amir A. Kazmi acquired 2,545 shares of Ralliant stock in a transaction dated Friday, February 6th. The shares were purchased at an average cost of $39.27 per share, with a total value of $99,942.15. Following the completion of the transaction, the senior vice president directly owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 8,145 shares of company stock valued at $332,233.

Ralliant Stock Up 1.8%

Shares of RAL stock opened at $46.72 on Tuesday. The stock has a 50 day moving average of $49.39 and a 200-day moving average of $46.61. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The firm has a market cap of $5.22 billion and a PE ratio of 23.84.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. Ralliant’s revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.

Analysts Set New Price Targets

RAL has been the subject of a number of recent analyst reports. Zacks Research downgraded Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research report on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 target price on shares of Ralliant in a research note on Friday, February 6th. Barclays dropped their price target on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Finally, Weiss Ratings lowered Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research report on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $50.50.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.